This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

This study is currently recruiting participants.
See Contacts and Locations
Verified August 2017 by American Foundation for Addiction Research
Sponsor:
Collaborators:
University of Alberta
University of Southern Mississippi
Information provided by (Responsible Party):
American Foundation for Addiction Research
ClinicalTrials.gov Identifier:
NCT02844985
First received: June 17, 2016
Last updated: August 4, 2017
Last verified: August 2017
  Purpose
The study is intended to identify gene polymorphisms significantly associated with specific behavioral- and preoccupation-typologies of sexual addiction, and to identify additional potential genetic markers of sexual addiction. Research subjects with sexual addiction will be identified from the out-patient and in-patient populations of the investigative sites. Research subjects in the Control Group will be identified from the general population and from the student body of selected colleges. Approximately 1100 subjects will be enrolled in the study. Anticipating 10% drop-out, this is intended to generate a population of approximately 500 men and women clinically diagnosed with sexual addiction, and approximately 500 healthy men and women who do not meet diagnostic criteria for sexual addiction nor have psychopathology who will serve as the control population.

Condition Intervention
Sexual Addiction Other: No Intervention

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Cross-Sectional
Official Title: Genetic Markers in Sexual Addiction

Resource links provided by NLM:


Further study details as provided by American Foundation for Addiction Research:

Primary Outcome Measures:
  • Gene polymorphisms identified through polymerase chain reaction using fluorescent primers and restriction fragment length polymorphism analysis [ Time Frame: Assessed at Enrollment ]

Biospecimen Retention:   Samples With DNA
Saliva specimens will be collected from all participants for genetic evaluation.

Estimated Enrollment: 1100
Actual Study Start Date: August 17, 2016
Estimated Study Completion Date: June 2018
Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Addict Group
In-patient and out-patient adult men and women who meet diagnostic criteria for sexual addiction.
Other: No Intervention
Control Group
Individuals from the general community and college student populations who have no history of identifiable psychopathology.
Other: No Intervention

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Sexual Addict Group: individuals undergoing treatment for sexual addiction.

Control Group: individuals from general community who have no history of addiction or psychopathology

Criteria

Inclusion Criteria:

  • Sexual Addict Group

Age >= 18 years

Participating in sexual addiction treatment program

Sexual Addiction Screening Test--Revised (SAST-R) score >= 11

Meets at least 3 diagnostic criteria for sexual addiction

  • Control Group

Age >= 18 years

SAST-R score < 6

Exclusion Criteria:

  • Sexual Addiction Group

Serious mental illness

Significant cognitive impairment

  • Control Group

History of addiction

Current or previous Diagnostic and Statistical Manual (DSM-5) diagnosis

Serious mental illness

Significant cognitive impairment

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02844985

Contacts
Contact: Executive Director 480-488-7053 study@addictionresearch.com

Locations
United States, Arizona
Psychological Counseling Services Recruiting
Scottsdale, Arizona, United States, 85251
Contact: Richard Isenberg, MD    480-947-5739    rick.isenberg.md@pcsearle.com   
Principal Investigator: Richard A Isenberg, MD         
Gentle Path at The Meadows Recruiting
Wickenburg, Arizona, United States, 85390
Contact: Isabel de Guzman, PhD    928-684-4080    ideguzman@gentlepathmeadows.com   
Sub-Investigator: Isabel de Guzman, PhD         
Principal Investigator: Patrick Carnes, PhD         
United States, California
Center for Healthy Sex Recruiting
Los Angeles, California, United States, 90025
Contact: Piper Grant, PhD    310-843-9902    piper@centerforhealthysex.com   
Principal Investigator: Alexandra Katehakis, MFT         
Triune Therapy Group Recruiting
Los Angeles, California, United States, 90025
Contact: Kate Balestrieri, PsyD    310-933-4088    kate@triunetherapy.com   
Principal Investigator: Kate Balestrieri, PsyD         
United States, Mississippi
Pine Grove Behavioral Health and Addiction Services Recruiting
Hattiesburg, Mississippi, United States, 39402
Contact: Gregory L Futral, PhD    601-288-4999    gfutral@forrestgeneral.com   
Principal Investigator: Gregory L Futral, PhD         
United States, New York
Kavod Center Recruiting
Rochester, New York, United States, 14607
Contact: Michelle Laugh, MS    585-546-5180    morris@rpa.net   
Principal Investigator: Daniel A MORRIS, LCSW         
United States, Texas
Center for Healthy Sexuality Recruiting
Houston, Texas, United States, 77057
Contact: Mark Bourliea    713-785-7111      
Principal Investigator: Barbara Levinson, PhD         
United States, Washington
Seattle Christian Counseling Recruiting
Bellevue, Washington, United States, 98004
Contact: Chris Chandler, LMHC    425-289-9589    chris@seattlechristiancounseling.com   
Principal Investigator: Christopher Chandler, LMHC         
Sponsors and Collaborators
American Foundation for Addiction Research
University of Alberta
University of Southern Mississippi
  More Information

Responsible Party: American Foundation for Addiction Research
ClinicalTrials.gov Identifier: NCT02844985     History of Changes
Other Study ID Numbers: AFAR 2016-001
Study First Received: June 17, 2016
Last Updated: August 4, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by American Foundation for Addiction Research:
Sexual Addiction
Genomics
Personality
Polymorphism

Additional relevant MeSH terms:
Behavior, Addictive
Compulsive Behavior
Impulsive Behavior

ClinicalTrials.gov processed this record on August 18, 2017